Life Stance Health Group, Inc. LFST
We take great care to ensure that the data presented and summarized in this overview for LifeStance Health Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LFST
View all-
Tpg Gp A, LLC Fort Worth, TX161MShares$1.09 Billion32.69% of portfolio
-
Summit Partners L P41.9MShares$286 Million71.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$72.8 Million0.0% of portfolio
-
Durable Capital Partners LP Bethesda, MD9.51MShares$64.8 Million0.61% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$56.7 Million0.0% of portfolio
-
Jennison Associates LLC8.09MShares$55.1 Million0.04% of portfolio
-
Morgan Stanley New York, NY7MShares$47.7 Million0.0% of portfolio
-
Brown Advisory Inc6.01MShares$41 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.47MShares$37.3 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA5.28MShares$35.9 Million0.01% of portfolio
Latest Institutional Activity in LFST
Top Purchases
Top Sells
About LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Insider Transactions at LFST
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2025
|
Lisa K Miller |
SELL
Open market or private sale
|
Direct |
18,845
-5.25%
|
$113,070
$6.9 P/Share
|
|
Mar 10
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Open market or private sale
|
Indirect |
15,605
-2.9%
|
$109,235
$7.64 P/Share
|
|
Mar 07
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Open market or private sale
|
Indirect |
19,900
-3.57%
|
$139,300
$7.29 P/Share
|
|
Mar 07
2025
|
David Bourdon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72,501
-4.03%
|
$507,507
$7.59 P/Share
|
|
Mar 07
2025
|
David Bourdon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
205,550
+10.2%
|
-
|
|
Mar 07
2025
|
Kenneth A Burdick |
SELL
Payment of exercise price or tax liability
|
Direct |
278,192
-4.04%
|
$1,947,344
$7.59 P/Share
|
|
Mar 07
2025
|
Kenneth A Burdick |
BUY
Grant, award, or other acquisition
|
Direct |
706,962
+9.3%
|
-
|
|
Mar 07
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,554
-1.46%
|
$304,878
$7.59 P/Share
|
|
Mar 07
2025
|
Pablo Pantaleoni Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,343
+4.48%
|
-
|
|
Mar 07
2025
|
Ann Varanakis Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,331
-1.62%
|
$86,317
$7.59 P/Share
|
|
Mar 07
2025
|
Ann Varanakis Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,792
+7.38%
|
-
|
|
Mar 07
2025
|
Ryan Pardo |
SELL
Payment of exercise price or tax liability
|
Direct |
41,825
-2.23%
|
$292,775
$7.59 P/Share
|
|
Mar 07
2025
|
Ryan Pardo |
BUY
Grant, award, or other acquisition
|
Direct |
137,484
+6.77%
|
-
|
|
Mar 07
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,544
-4.66%
|
$45,808
$7.59 P/Share
|
|
Mar 07
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,805
+12.91%
|
-
|
|
Mar 06
2025
|
David Bourdon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,767
-2.14%
|
$117,369
$7.88 P/Share
|
|
Mar 06
2025
|
David Bourdon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
348,985
+30.83%
|
-
|
|
Mar 06
2025
|
Kenneth A Burdick |
SELL
Payment of exercise price or tax liability
|
Direct |
53,602
-1.77%
|
$375,214
$7.88 P/Share
|
|
Mar 06
2025
|
Kenneth A Burdick |
BUY
Grant, award, or other acquisition
|
Direct |
95,178
+3.05%
|
-
|
|
Mar 06
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,444
-1.37%
|
$136,108
$7.88 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.37M shares |
|---|
| Payment of exercise price or tax liability | 577K shares |
|---|---|
| Open market or private sale | 29.8M shares |